NARA Discovery
Article Details
← Back to Search Results
Journal Article

Harnessing FDA-approved dipyridamole to inhibit NLRP3 inflammasome and improve outcomes of acute lung injury in sepsis

Xiuhui Chen; Yutong Zheng; Xiaofeng Zhang; Anran Zheng; Junjun Huang; Guoliang Deng; Xuna Wu; Yuying Peng; Xiaoling Zhang; Renshan Chen; Qing Xiao; Weijun Ye
Toxicology and Applied Pharmacology · Vol. 500 · pp. 117383 · 2025
View Full Text Download RIS Journal Homepage

Abstract

Abstract is unavailable.

Bibliographic Information

JournalToxicology and Applied Pharmacology
PublisherAcademic Press
Publication Date2025-07-01
Publication Year2025
Volume500
Pages117383
Document TypeJournal Article
eISSN0041-008X
DOI10.1016/j.taap.2025.117383
SubjectEnvironmental Science

Access Information

NARA Access Coverage1959-01-01~Current
Journal Homepagehttps://www.sciencedirect.com/science/journal/0041008X
Publisher PageOpen Publisher Page
Full-text access depends on NARA's subscribed coverage and institutional access.